These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21558621)

  • 1. CD20 antigen imaging with ¹²⁴I-rituximab PET/CT in patients with rheumatoid arthritis.
    Tran L; Huitema AD; van Rijswijk MH; Dinant HJ; Baars JW; Beijnen JH; Vogel WV
    Hum Antibodies; 2011; 20(1-2):29-35. PubMed ID: 21558621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of ¹²⁴I-rituximab in patients with rheumatoid arthritis.
    Tran L; Vogel WV; Sinaasappel M; Muller S; Baars JW; van Rijswijk M; Dinant HJ; Beijnen JH; Huitema AD
    Hum Antibodies; 2011; 20(1-2):7-14. PubMed ID: 21558619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of ¹³¹I-rituximab in a patient with CD20 positive non-Hodgkin Lymphoma: evaluation of the effect of radioiodination on the biological properties of rituximab.
    Tran L; Baars JW; de Boer JP; Hoefnagel CA; Beijnen JH; Huitema AD
    Hum Antibodies; 2011; 20(1-2):37-40. PubMed ID: 21558622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis as a means to predict responsiveness to rituximab treatment.
    Teng YK; Levarht EW; Hashemi M; Bajema IM; Toes RE; Huizinga TW; van Laar JM
    Arthritis Rheum; 2007 Dec; 56(12):3909-18. PubMed ID: 18050222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation.
    Teng YK; Levarht EW; Toes RE; Huizinga TW; van Laar JM
    Ann Rheum Dis; 2009 Jun; 68(6):1011-6. PubMed ID: 18647852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased CD20 expression in rheumatoid arthritis synovium following 8 weeks of rituximab therapy.
    Walsh CA; Fearon U; FitzGerald O; Veale DJ; Bresnihan B
    Clin Exp Rheumatol; 2008; 26(4):656-8. PubMed ID: 18799100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of rituximab's immunomodulatory synovial effects (ARISE trial). 1: clinical and synovial biomarker results.
    Kavanaugh A; Rosengren S; Lee SJ; Hammaker D; Firestein GS; Kalunian K; Wei N; Boyle DL
    Ann Rheum Dis; 2008 Mar; 67(3):402-8. PubMed ID: 17644541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience.
    Shaw T; Quan J; Totoritis MC
    Ann Rheum Dis; 2003 Nov; 62 Suppl 2(Suppl 2):ii55-9. PubMed ID: 14532151
    [No Abstract]   [Full Text] [Related]  

  • 9. B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthritis patients.
    Bruijnen S; Tsang-A-Sjoe M; Raterman H; Ramwadhdoebe T; Vugts D; van Dongen G; Huisman M; Hoekstra O; Tak PP; Voskuyl A; van der Laken C
    Arthritis Res Ther; 2016 Nov; 18(1):266. PubMed ID: 27863504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Next-Generation Anti-CD20 Antibodies Labeled with
    Yoon JT; Longtine MS; Marquez-Nostra BV; Wahl RL
    J Nucl Med; 2018 Aug; 59(8):1219-1224. PubMed ID: 29348316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell: a logical target for treatment of rheumatoid arthritis.
    Youinou P; Jamin C; Saraux A
    Clin Exp Rheumatol; 2007; 25(2):318-28. PubMed ID: 17543163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-CD20 antibody therapy for inflammatory immune diseases].
    Tanaka Y
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1801-6. PubMed ID: 17037318
    [No Abstract]   [Full Text] [Related]  

  • 13. The anti-CD20 antibody rituximab reduces the Th17 cell response.
    van de Veerdonk FL; Lauwerys B; Marijnissen RJ; Timmermans K; Di Padova F; Koenders MI; Gutierrez-Roelens I; Durez P; Netea MG; van der Meer JW; van den Berg WB; Joosten LA
    Arthritis Rheum; 2011 Jun; 63(6):1507-16. PubMed ID: 21400475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The alternative CD20 transcript variant is not a surrogate marker for resistance to rituximab in patients with rheumatoid arthritis.
    Gamonet C; Deschamps M; Marion S; Herbein G; Chiocchia G; Auger I; Saas P; Ferrand C; Toussirot E
    Rheumatology (Oxford); 2015 Sep; 54(9):1744-5. PubMed ID: 26117335
    [No Abstract]   [Full Text] [Related]  

  • 15. [Targeting CD20 in rheumatoid arthritis].
    Saito K; Tanaka Y
    Nihon Rinsho; 2007 Jul; 65(7):1243-9. PubMed ID: 17642239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis.
    Rehnberg M; Amu S; Tarkowski A; Bokarewa MI; Brisslert M
    Arthritis Res Ther; 2009; 11(4):R123. PubMed ID: 19686595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity.
    Kormelink TG; Tekstra J; Thurlings RM; Boumans MH; Vos K; Tak PP; Bijlsma JW; Lafeber FP; Redegeld FA; van Roon JA
    Ann Rheum Dis; 2010 Dec; 69(12):2137-44. PubMed ID: 20679475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab.
    Muylle K; Flamen P; Vugts DJ; Guiot T; Ghanem G; Meuleman N; Bourgeois P; Vanderlinden B; van Dongen GA; Everaert H; Vaes M; Bron D
    Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1304-14. PubMed ID: 25792453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immuno-PET and Immuno-SPECT of Rheumatoid Arthritis with Radiolabeled Anti-Fibroblast Activation Protein Antibody Correlates with Severity of Arthritis.
    Laverman P; van der Geest T; Terry SY; Gerrits D; Walgreen B; Helsen MM; Nayak TK; Freimoser-Grundschober A; Waldhauer I; Hosse RJ; Moessner E; Umana P; Klein C; Oyen WJ; Koenders MI; Boerman OC
    J Nucl Med; 2015 May; 56(5):778-83. PubMed ID: 25858044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rituximab treatment of rheumatoid arthritis: new evidence].
    Nasonov EL
    Ter Arkh; 2009; 81(6):82-91. PubMed ID: 19663200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.